Impact of Brucellosis on Interleukin -23 Level, Acid Phosphates and Some Other Trace Elements
Journal of Pure and Applied Microbiology, 2018 The study was carried out during a period of February 2017-July 2018 for the detection of brucellosis in 128 suspected patients with age group range from 17 - 69 years, who attended to Baghdad teaching hospitals, that had been examined and defined as ...
Khalil Ismail A. Mohamed +6 more
doaj +2 more sources
Interleukin-23 in perspective. [PDF]
Rheumatology (Oxford), 2021 Sherlock JP, Cua DJ.
europepmc +4 more sources
Differential regulation of interleukin-17 and interferon-y production in inflammatory bowel disease [PDF]
, 2010 PhDBackground and Aims. Interleukin (IL)-17 is now known to be involved in a number of chronic inflammatory disorders. However, the mechanisms regulating its production in inflammatory bowel disease (IBD) are still unclear. Methods.
Rovedatti, Laura
core +4 more sources
Interleukin 23 in Crohnʼs Disease [PDF]
Inflammatory Bowel Diseases, 2014 : Crohn's disease (CD) is a lifelong inflammatory condition with underlying environmental and genetic components. CD affects multiple parts of the gastrointestinal tract, and it has a growing incidence in Western societies. IL-23 receptor variants have been identified as susceptibility or resistance factors for CD in genome-wide association studies ...
Oukka, Mohamed +2 more
openaire +3 more sources
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices. [PDF]
Biologics, 2023 Maysa M Haroon,1 Gehan A Hegazy,2,3 Mohammed A Hassanien,4,5 Olfat Shaker,6 Wafaa H Hussein1 1Department of Rheumatology, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Clinical Biochemistry Department, Faculty of Medicine, King Abdulaziz ...
Haroon MM +4 more
europepmc +2 more sources
Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment [PDF]
Therapeutic Advances in Chronic Disease, 2018 Plaque psoriasis is one of the most common autoimmune skin diseases and is characterized by erythematous, scaly plaques. Many highly effective, targeted therapies have been developed as a result of an improved understanding of the pathogenesis of psoriasis.
Tom C, Chan +2 more
openaire +2 more sources
Use of NanoBiT and NanoBRET to characterise interleukin-23 receptor dimer formation in living cells. [PDF]
Br J Pharmacol, 2023 Background and Purpose: Interleukin-23 (IL-23) and its receptor are important drug targets for the treatment of auto-inflammatory diseases. IL-23 binds to a receptor complex composed of two single transmembrane spanning proteins IL23R and IL12Rβ1.
Lay CS +3 more
europepmc +2 more sources
Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis
, 2015 The cytokines interleukin (IL)-12 and interleukin (IL)-23 have been implicated variously in the pathogenesis of psoriasis and psoriatic arthritis (PsA).
McInnes, I.B., Johnsson, H.J.
core +7 more sources
ES-62 protects against collagen-induced arthritis by resetting interleukin-22 towards resolution of inflammation in the joints [PDF]
, 2014 Objective. The parasitic worm–derived immunomodulator ES-62 protects against disease in the mouse collagen-induced arthritis (CIA) model of rheumatoid arthritis (RA) by suppressing pathogenic interleukin-17 (IL-17) responses. The Th17 associated cytokine
Al-Riyami, Lamyaa +4 more
core +3 more sources
Regulation of Interleukin-23 Receptor expression in human T-Lymphocytes [PDF]
, 2022 openChronic inflammatory diseases (CID) are clinically heterogeneous conditions that share common inflammatory pathways and derive from aberrant immune responses.
CREMA, ALESSIA
core